Swedish Orphan Biovitrum AB (publ)
Swedish Orphan Biovitrum AB (publ) (BIOVF) Stock Overview
Explore Swedish Orphan Biovitrum AB (publ)’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
16.4B
P/E Ratio
162.17
EPS (TTM)
$0.28
ROE
0.02%
BIOVF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Swedish Orphan Biovitrum AB (publ) (BIOVF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 95.95, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $36.11.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 162.17 and a market capitalization of 16.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.